iOS CamAPS FX
CamDiab · Decision date Sep 16, 2026
What did the FDA decide?
FDA records K261896 as a 510(k) premarket notification, with a decision dated Sep 16, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Clinical Chemistry
- Decision date
- Sep 16, 2026
Regulatory record facts
- Identifier
- K261896
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- CamDiab
- Product code
- QJI
- Decision code
- SESE
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Interoperable Automated Glycemic Controller.
FDA decision timeline
K261896 received
Application receipt date recorded by FDA.
K261896 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code QJI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
twiist Loop AlgorithmK262576 | Deka Research and Development Corp. | 510(k) clearance | Oct 15, 2026 | FDA |
| Beta Bionics, Inc. | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
CamDiab
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- London
Sources and methodology
- Original FDA record: K261896
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records